These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1380181)

  • 1. A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells.
    Latron F; Pazmany L; Morrison J; Moots R; Saper MA; McMichael A; Strominger JL
    Science; 1992 Aug; 257(5072):964-7. PubMed ID: 1380181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes.
    Morrison J; Elvin J; Latron F; Gotch F; Moots R; Strominger JL; McMichael A
    Eur J Immunol; 1992 Apr; 22(4):903-7. PubMed ID: 1372560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positioning of a peptide in the cleft of HLA-A2 by complementing amino acid changes.
    Latron F; Moots R; Rothbard JB; Garrett TP; Strominger JL; McMichael A
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11325-9. PubMed ID: 1763045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide binding to MHC class I is determined by individual pockets in the binding groove.
    Johansen TE; McCullough K; Catipovic B; Su XM; Amzel M; Schneck JP
    Scand J Immunol; 1997 Aug; 46(2):137-46. PubMed ID: 9583994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics study of a complex between the human histocompatibility antigen HLA-A2 and the IMP58-66 nonapeptide from influenza virus matrix protein.
    Rognan D; Zimmermann N; Jung G; Folkers G
    Eur J Biochem; 1992 Aug; 208(1):101-13. PubMed ID: 1511679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both major and minor peptide-binding pockets in HLA-A2 influence the presentation of influenza virus matrix peptide to cytotoxic T lymphocytes.
    Teng JM; Hogan KT
    Mol Immunol; 1994 Apr; 31(6):459-70. PubMed ID: 8183284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of peptide binding to HLA-A2 and the conformation of the peptide-A2 complex can be determined by amino acid side chains on the floor of the peptide binding groove.
    Shimojo N; Anderson RW; Mattson DH; Turner RV; Coligan JE; Biddison WE
    Int Immunol; 1990; 2(3):193-200. PubMed ID: 2088485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope-enhanced conserved HIV-1 peptide protects HLA-A2-transgenic mice against virus expressing HIV-1 antigen.
    Okazaki T; Pendleton CD; Lemonnier F; Berzofsky JA
    J Immunol; 2003 Sep; 171(5):2548-55. PubMed ID: 12928405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.
    Matsui M; Moots RJ; McMichael AJ; Frelinger JA
    Hum Immunol; 1994 Oct; 41(2):160-6. PubMed ID: 7860362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.
    Wang Z; Turner R; Baker BM; Biddison WE
    J Immunol; 2002 Sep; 169(6):3146-54. PubMed ID: 12218132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice.
    Man S; Newberg MH; Crotzer VL; Luckey CJ; Williams NS; Chen Y; Huczko EL; Ridge JP; Engelhard VH
    Int Immunol; 1995 Apr; 7(4):597-605. PubMed ID: 7547687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.
    Hausmann S; Biddison WE; Smith KJ; Ding YH; Garboczi DN; Utz U; Wiley DC; Wucherpfennig KW
    J Immunol; 1999 May; 162(9):5389-97. PubMed ID: 10228016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
    Robbins PA; Lettice LA; Rota P; Santos-Aguado J; Rothbard J; McMichael AJ; Strominger JL
    J Immunol; 1989 Dec; 143(12):4098-103. PubMed ID: 2480387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens.
    Winter CC; Carreno BM; Turner RV; Koenig S; Biddison WE
    J Immunol; 1991 May; 146(10):3508-12. PubMed ID: 2026879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.
    Hogan KT; Shimojo N; Walk SF; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Exp Med; 1988 Aug; 168(2):725-36. PubMed ID: 3261776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.
    Alexander-Miller MA; Parker KC; Tsukui T; Pendleton CD; Coligan JE; Berzofsky JA
    Int Immunol; 1996 May; 8(5):641-9. PubMed ID: 8671651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of peptides that bind to the HLA-A2.1 molecule by molecular modelling.
    Lim JS; Kim S; Lee HG; Lee KY; Kwon TJ; Kim K
    Mol Immunol; 1996 Feb; 33(2):221-30. PubMed ID: 8649443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein.
    Engelhard VH; Lacy E; Ridge JP
    J Immunol; 1991 Feb; 146(4):1226-32. PubMed ID: 1704033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition.
    Tussey LG; Matsui M; Rowland-Jones S; Warburton R; Frelinger JA; McMichael A
    J Immunol; 1994 Feb; 152(3):1213-21. PubMed ID: 8301126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.
    Moots RJ; Matsui M; Pazmany L; McMichael AJ; Frelinger JA
    Immunogenetics; 1991; 34(3):141-8. PubMed ID: 1894308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.